Study limitation: The 'practice changing' impact flag reflects the proposed paradigm shift in disease classification, not a clinical trial outcome | ReachRx
TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging
Study limitation reported by the research below: “The 'practice changing' impact flag reflects the proposed paradigm shift in disease classification, not a clinical trial outcome.”